ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014 1:13:45 PM
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/24/2014 4:28:54 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014 7:53:13 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Proposed Settlement Of Pending Securities Class Action Lawsuit 11/4/2014 7:25:32 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David J. Caponera As Vice President Patient Advocacy And Reimbursement 10/28/2014 7:13:30 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Firdapse Phase 3 Trial Results At The 61st Annual Meeting Of The American Association Of Neuromuscular And Electrodiagnostic Medicine 10/27/2014 7:33:40 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Top-Line Safety And Efficacy Results From Phase 3 Firdapse Trial At 139th Annual Meeting Of The American Neurological Association 10/8/2014 7:19:36 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Will Hire 25 Staffers After Successful Drug Trial 10/7/2014 6:26:26 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial In Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) 9/29/2014 1:12:57 PM
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David D. Muth As Executive Vice President, Corporate Development 9/4/2014 8:51:00 AM
12345678910...